Agilent Technologies Acquires Qiming-backed Biotechnology Firm ACEA Biosciences
September 27, 2018 — 14:33 CST
This Data Is Locked!
This area is available only to Subscribers.
US-based Agilent Technologies has signed a definitive agreement to acquire privately-owned biotechnology company ACEA Biosciences for $250 million in cash. The acquisition will enable Agilent... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals